5 authorised products containing Ibandronate sodium monohydrate, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Ibandronic Acid 150 mg film-coated tablets PA2315/184/001 |
Ibandronate sodium monohydrate | Accord Healthcare Ireland Ltd. | Marketed |
| Ibandronic Acid 6 mg Concentrate for Solution for Infusion PA1122/018/001 |
Ibandronate sodium monohydrate | Noridem Enterprises Limited | Not marketed |
| Ibandronic acid Accord 2 mg concentrate for solution for infusion EU/1/12/798/001 |
Ibandronate sodium monohydrate | Accord Healthcare S.L.U. | — |
| Ibandronic acid Accord 3 mg solution for injection in pre-filled syringe EU/1/12/798/005-006 |
Ibandronic acid, Ibandronate sodium monohydrate, Ibandronate sodium | Accord Healthcare S.L.U. | — |
| Ibandronic acid Accord 6 mg concentrate for solution for infusion EU/1/12/798/002-004 |
Ibandronate sodium monohydrate | Accord Healthcare S.L.U. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.